Agent skill

protac-design-agent

Stars 163
Forks 31

Install this agent skill to your Project

npx add-skill https://github.com/majiayu000/claude-skill-registry/tree/main/skills/data/protac-design-agent

SKILL.md

---name: protac-design-agent description: AI-powered PROTAC (Proteolysis Targeting Chimera) design for targeted protein degradation, integrating ternary complex prediction, linker optimization, and ADMET modeling. license: MIT metadata: author: AI Group version: "1.0.0" created: "2026-01-20" compatibility:

  • system: Python 3.10+ allowed-tools:
  • run_shell_command
  • read_file
  • write_file

keywords:

  • protac-design-agent
  • automation
  • biomedical measurable_outcome: execute task with >95% success rate. ---"

PROTAC Design Agent

The PROTAC Design Agent provides AI-assisted design of Proteolysis Targeting Chimeras (PROTACs) for targeted protein degradation. It integrates machine learning for ternary complex prediction, linker design, E3 ligase selection, and ADMET optimization to accelerate degrader drug discovery for oncology and other therapeutic areas.

When to Use This Skill

  • When designing PROTAC degraders for a target protein.
  • For optimizing linker chemistry and length.
  • To predict ternary complex formation and degradation efficiency.
  • When selecting optimal E3 ligase (CRBN, VHL) for the target.
  • For optimizing ADMET properties of degrader molecules.

Core Capabilities

  1. Warhead Selection: Identify optimal target protein ligands.

  2. E3 Ligase Selection: Choose CRBN, VHL, or other E3 recruiters.

  3. Linker Design: Optimize linker length, chemistry, and rigidity.

  4. Ternary Complex Prediction: Model POI-PROTAC-E3 formation.

  5. Degradation Efficiency Modeling: Predict DC50 and Dmax.

  6. ADMET Optimization: Balance potency with drug-like properties.

PROTAC Components

Component Function Optimization Target
Warhead Binds target protein (POI) Affinity, selectivity
E3 Ligand Recruits E3 ubiquitin ligase CRBN/VHL binding
Linker Connects warhead to E3 ligand Length, flexibility, solubility

E3 Ligase Options

E3 Ligase Ligand Tissue Expression Advantages
CRBN Thalidomide analogs Ubiquitous Well-characterized
VHL VHL ligands Ubiquitous High selectivity
MDM2 Nutlin analogs Variable p53-independent
IAP SMAC mimetics High in cancer Dual mechanism
DCAF15 Indisulam Variable Novel chemistry

Workflow

  1. Input: Target protein structure/sequence, known ligands (optional).

  2. Warhead Design: Generate/optimize POI binding moiety.

  3. E3 Selection: Choose optimal E3 ligase for target/tissue.

  4. Linker Library: Generate diverse linker options.

  5. Ternary Complex Modeling: Predict complex formation.

  6. Ranking: Score by predicted degradation and ADMET.

  7. Output: Ranked PROTAC designs with synthesis routes.

Example Usage

User: "Design a PROTAC to degrade BRD4 using CRBN as the E3 ligase, optimizing for oral bioavailability."

Agent Action:

bash
python3 Skills/Drug_Discovery/PROTAC_Design_Agent/design_protac.py \
    --target BRD4 \
    --target_structure pdb:3MXF \
    --warhead_smiles "JQ1_core_smiles" \
    --e3_ligase CRBN \
    --linker_library peg,alkyl,piperdine \
    --linker_length_range 4,12 \
    --optimize_oral true \
    --output protac_designs/

Linker Design Parameters

Parameter Options Consideration
Length 2-20 atoms Ternary complex geometry
Chemistry PEG, alkyl, piperazine, triazole Solubility, stability
Rigidity Flexible vs constrained Entropic penalty
Attachment Connectivity points Exit vector matching
MW Contribution Varies Total MW impact

Output Components

Output Description Format
PROTAC Structures Designed molecules .sdf, SMILES
Ternary Models POI-PROTAC-E3 complexes .pdb
Predicted DC50 Degradation potency .csv
Predicted Dmax Maximum degradation .csv
ADMET Predictions Solubility, permeability, etc. .csv
Synthesis Routes Retrosynthetic analysis .json
Ranking Prioritized designs .csv

Degradation Efficiency Metrics

Metric Definition Target
DC50 Concentration for 50% degradation <100 nM
Dmax Maximum degradation achieved >90%
Kinetics Time to half-degradation <4 hours
Selectivity Off-target degradation Minimal
Hook Effect High-dose attenuation Minimal

AI/ML Components

Ternary Complex Prediction:

  • AlphaFold-Multimer adaptation
  • Geometric deep learning
  • Molecular dynamics validation

Degradation Modeling:

  • Quantitative degradation prediction
  • Transfer learning from degrader databases
  • Multi-task learning (DC50, Dmax, kinetics)

Linker Optimization:

  • Generative models (VAE, diffusion)
  • Reinforcement learning
  • Multi-objective Bayesian optimization

ADMET Prediction:

  • Property prediction models
  • Chameleonicity assessment
  • Oral bioavailability scoring

Clinical Pipeline Status (2026)

PROTAC Target Phase E3 Ligase
ARV-471 ER Phase 3, NDA filed CRBN
ARV-110 AR Phase 2 CRBN
BGB-16673 BTK Phase 3 CRBN
NX-2127 BTK Phase 2 CRBN
KT-474 IRAK4 Phase 2 CRBN

Design Considerations

Factor PROTAC Challenge Solution
High MW Poor permeability Chameleonicity
Low Solubility Limited exposure Solubilizing groups
Hook Effect Reduced efficacy at high doses Optimize binding balance
E3 Saturation Competition with other PROTACs Target expression

Prerequisites

  • Python 3.10+
  • RDKit, Open Babel
  • AlphaFold2/3
  • Molecular dynamics (GROMACS/OpenMM)
  • PyTorch for ML models

Related Skills

  • Molecular_Glue_Discovery_Agent - Glue degraders
  • TPD_Ternary_Complex_Agent - Complex prediction
  • Molecular_Docking_Agent - Docking analysis
  • ADMET_Prediction_Agent - Property prediction

ADMET Optimization Strategies

Property Challenge Approach
Permeability High MW limits Intramolecular H-bonds
Solubility Lipophilicity Polar linker groups
Metabolic Stability Linker metabolism Stable chemistries
Clearance High metabolism Optimize logD

Special Considerations

  1. Target Suitability: Not all proteins are degradable
  2. E3 Expression: Check tissue-specific E3 levels
  3. Ubiquitination Sites: Surface lysines needed
  4. Resistance: Target mutations, E3 downregulation
  5. Selectivity: Validate off-target degradation

Quality Control Metrics

QC Check Threshold Rationale
Ternary Complex Score >0.7 Productive complex
Linker Strain <5 kcal/mol Favorable geometry
ADMET Score >0.5 Drug-like properties
Synthetic Accessibility <5 Feasible synthesis

Author

AI Group - Biomedical AI Platform

Expand your agent's capabilities with these related and highly-rated skills.

Didn't find tool you were looking for?

Be as detailed as possible for better results